The National Agency for Food and Drug Administration and Control (NAFDAC) has announced that it will continue hydroxychloroquine clinical trials for the treatment of COVID-19 in Nigeria.
This is coming despite the suspension of the same trial by the World Health Organisation.
NAFDAC Director-General, Prof Mojisola Adeyeye, made this known on Tuesday during a programme on Television Continental.
Adeyeye said there are proven records that hydroxychloroquine had been effective in the treatment of COVID-19 patients, especially those at the “mild stage” of the virus.
via: Information Nigeria